companydata.dkbiomee ApS: Financial statements 2018
CVR: 29829586
biomee ApS (CVR 29829586) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -386,013 and a net result of DKK -2,372,896 compared with DKK -4,230,706 the year before. Equity amounted to DKK -52,444,656.
- Gross Profit
- -386,013 kr.
- Profit/Loss
- -2,372,896 kr.
- Equity
- -52,444,656 kr.
- Total Assets
- 3,410,771 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -386 t. | -2.4 mio. | -52.4 mio. | 0 |
| 2017 | - | -7.8 mio. | -4.2 mio. | -50.1 mio. | - |
| 2016 | - | -33 mio. | -38.7 mio. | -45.8 mio. | - |
| 2015 | - | -32.2 mio. | -33 mio. | -7.1 mio. | - |
| 2014 | - | -18.3 mio. | -17.2 mio. | -78.7 mio. | - |
Keep an eye on biomee ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
Biomee ApS has published its annual report for 2017. Gross profit came to DKK -7,813,359, and the net result was DKK -4,230,706.
About biomee ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity amounted to DKK 23,772,837.